Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.

A de Nonneville,A Gonçalves,C Zemmour,M Cohen,J M Classe,F Reyal,P E Colombo,E Jouve,S Giard,E Barranger,R Sabatier,F Bertucci,J M Boher,G Houvenaeghel

European Journal of Cancer（2017）

引用 26|浏览53

暂无评分

摘要

•Consensus guidelines recommend consideration of treatment in patients with triple-negative breast cancer larger than 5 mm.•We did not identify significant advantage for adjuvant chemotherapy in pT1abN0M0 TNBC patients.•Clinicians should carefully discuss benefit/risk ratio with patients.

查看译文

关键词

Adjuvant chemotherapy,Breast cancer,pT1ab,Node-negative,Triple-negative

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要